Bourgeon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bourgeon Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-62	Closed	-$4K	–	276
2021 Q2	$4K	Hold	62	–	–	﹤0.01%	253
2021 Q1	$4K	Hold	62	–	–	﹤0.01%	251
2020 Q4	$4K	Hold	62	–	–	﹤0.01%	240
2020 Q3	$4K	Hold	62	–	–	﹤0.01%	240
2020 Q2	$4K	Sell	62 -12,050	-99%	-$721K	﹤0.01%	223
2020 Q1	$675K	Buy	+12,112	New	+$740K	0.35%	48
2019 Q4	–	Sell	-9,400	Closed	-$477K	–	231
2019 Q3	$477K	Sell	9,400 -4,290	-31%	-$202K	0.26%	53
2019 Q2	$621K	Hold	13,690	–	–	0.36%	47
2019 Q1	$653K	Buy	+13,690	New	+$682K	0.38%	43
2017 Q4	–	Sell	-9,397	Closed	-$599K	–	88
2017 Q3	$599K	Buy	9,397 +797	+9%	+$46.5K	0.35%	54
2017 Q2	$479K	Sell	8,600 -1,880	-18%	-$102K	0.3%	55
2017 Q1	$570K	Buy	10,480 +2,900	+38%	+$159K	0.36%	52
2016 Q4	$443K	Buy	+7,580	New	+$414K	0.28%	63

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bourgeon Capital Management's BMY Position: Q3 2021 in Review

Bourgeon Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 62 shares — an estimated $4K sold.

Bourgeon Capital Management first reported a position in BMY in Q4 2016 and held it in 13 quarters. The position peaked at $675K in Q1 2020. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Bourgeon Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
Bourgeon Capital Management sold 62 Bristol-Myers Squibb shares in Q3 2021, an estimated $4K.
Bourgeon Capital Management first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 13 quarters.
Bourgeon Capital Management's Bristol-Myers Squibb position peaked at $675K in Q1 2020.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Bourgeon Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.